PDCD1 and esophageal squamous cell carcinoma: A real world study showed that PD-1 plus chemotherapy had favorable efficacy in operable locally advanced ESCC, with the ORR was 70.6%, DCR was 100%, R0 resection rate was 92.3%, and the pCR rate was 15.4% (Wu et al., 2021).